HUGE -- Oversold COVID-19 play; insiders buying at premium
I am in at $2.35.
- Oversold, RSI @ 21
- $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results
- Will need to maintain $4+ stock price to stay listed on NASDAQ
- Gaps above at 3.33 & 5.56
- Signs of bottoming out
-
25M in cash; with Cannabis asset sale (~20M), the cash position will exceed market cap
- Due for COVID-19 treatment Phase 2 trial results within a week or two
- Oversold, RSI @ 21
- $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results
- Will need to maintain $4+ stock price to stay listed on NASDAQ
- Gaps above at 3.33 & 5.56
- Signs of bottoming out
-
25M in cash; with Cannabis asset sale (~20M), the cash position will exceed market cap- Due for COVID-19 treatment Phase 2 trial results within a week or two
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.